Abstract
Current treatment for severe Native Aortic Valve Insufficiency (NAVI) is surgical aortic valve replacement (SAVR). For inoperable patients, few treatment options are available and outcomes are poor. NAVI is considered a relative contraindication for Transcatheter Aortic Valve Replacement (TAVR),
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
